(+)-JJ-74-138 is a novel non-competitive androgen receptor antagonist.
Sign Up to like & getrecommendations! Published in 2022 at "Molecular cancer therapeutics"
DOI: 10.1158/1535-7163.mct-21-0432
Abstract: Identification of novel androgen receptor (AR) antagonists may lead to urgently needed new treatments for prostate cancer patients resistant to current AR antagonists. AR is presently the main target for treating prostate cancer. Existing FDA-approved… read more here.
Keywords: 138 novel; novel non; androgen receptor; androgen ... See more keywords